Log in

Glenmark Pharmaceuticals

GLENMARK· NSE· Healthcare
₹2,655.80
−₹21.40 (−0.80%) · 1Das of 12 Nov 2026, 19:23 IST

Glenmark Pharmaceuticals (GLENMARK) last traded at ₹2,655.80 on NSE as of 12 Nov 2026, 19:23 IST, down 0.80% (−₹21.40) on the day. The stock is 2.1% below its 52-week high of ₹2,714.00 and 47.0% above its 52-week low of ₹1,807.00. Market cap ₹74,953 crore, trailing P/E 7,42,111.2×, P/B 7.1×, EPS ₹48.26. Sector: Healthcare.

Day range₹2,634.00 – ₹2,680.00
52-week range₹1,807.00 – ₹2,714.00
Volume8,85,1840.98× the 20-day average
Market cap₹74,953 crore
P/E · P/B7,42,111.2× · 7.1×trailing
EPS₹48.26
Returns1W+7.01%1M+16.33%3M+15.97%6M+17.66%YTD+30.49%1Y+43.73%3Y+248.14%5Y+407.03%

Fundamentals

Revenue growth· latest year+27.48%
Net margin0.0%
ROE / ROA0.0% / 0.0%
Debt-to-equity0.0×
P/E · P/B· trailing7,42,111.2× · 7.1×
EPS₹48.26
Revenue / net income₹16,983 crore / ₹0 crore
Last reported year ends 31 Mar 2026

Technicals

RSI (14)72.1
20-day average· 11.5% above₹2,382.07
50-day average· 11.5% above₹2,382.12
200-day average· 18.1% above₹2,248.08
ATR (14)· 3.20% of price₹85.06
20-session change+18.25%
Volatility· 30 sessions, annualised35.0%
From completed sessions; the RSI alone steps with the live price.

Sector today

Healthcare
Move today+0.04%
Breadth53% of stocks up
RotationImproving
Against the NIFTY 50 · breadth is the share of the sector's stocks up today

Latest news

All GLENMARK news ↗
  1. Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%
    Business Standard ↗ · 9 Nov 2026, 12:23 IST · Positive
  2. Motilal Oswal sets Glenmark Pharma target at Rs 3000
    Moneycontrol ↗ · 9 Nov 2026, 11:57 IST · Positive
  3. Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highs
    Business Standard ↗ · 6 Nov 2026, 15:15 IST · Positive
  4. Glenmark Pharma shares fall 4% after Q2 profit plunges 57%
    Business Today ↗ · 6 Nov 2026, 09:48 IST · Negative
  5. Glenmark Pharma shares react to better-than-expected US sales in Q2
    CNBC-TV18 ↗ · 6 Nov 2026, 07:19 IST · Negative
  6. Titan, Bharti, Britannia, Glenmark, Godfrey, NCC, KNR, Ashoka focus
    Moneycontrol ↗ · 6 Nov 2026, 07:15 IST · Positive
  7. Stocks in news: Bharti Airtel, LIC, Titan, ONGC, Bharti Hexacom, Glenmark Pharma and Astral
    Economic Times ↗ · 6 Nov 2026, 06:00 IST · Positive

Upcoming events

Event calendar ↗

No upcoming company event is listed for Glenmark Pharmaceuticals.

Frequently asked

What is the Glenmark Pharmaceuticals share price today?

Glenmark Pharmaceuticals (GLENMARK) last traded at ₹2,655.80 on NSE as of 12 Nov 2026, 19:23 IST, down 0.80% (−₹21.40) on the day.

What is the 52-week high and low of GLENMARK?

The 52-week range of Glenmark Pharmaceuticals is ₹1,807.00 to ₹2,714.00; the last price is 2.1% below the high.

What is the market capitalisation of Glenmark Pharmaceuticals?

₹74,953 crore at the last price (NSE's issued shares × price).

What is the P/E ratio of Glenmark Pharmaceuticals?

Trailing P/E 7,42,111.2× on EPS ₹48.26, from the annual statement for the year ended 31 Mar 2026.

Which sector is Glenmark Pharmaceuticals in, and how is the sector doing today?

Healthcare. The sector is up 0.04% today, with 53% of its stocks up (Improving against the NIFTY 50).

What is the next scheduled event for Glenmark Pharmaceuticals?

No upcoming company event is listed for Glenmark Pharmaceuticals.

Data as of 12 Nov 2026, 19:23 IST · Research, not investment advice.